BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2019
View Archived Issues
Optimization of quinazoline-based BET inhibitors for cancer and inflammatory diseases
Read More
Results of phase IIb trial of topical PAC-14028, a TRPV1 antagonist, in atopic dermatitis
Read More
Knopp Biosciences presents positive preclinical data for neonatal epilepsy drug candidate KB-3061
Read More
Crystal healing -- it's science!
Read More
Targeting cancer stem cell metabolism
Read More
Circulating exosomes may serve as biomarker of stem cell effectiveness
Read More
In vitro proof of concept for Immatics' TCER immunotherapy
Read More
Novel PI3Kdelta-selective inhibitors based on 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones
Read More
ALK2 inhibitors prolong survival in xenograft model of ACVR1 mutant diffuse intrinsic pontine glioma
Read More
JNJ-28583113, a novel specific TRPM2 antagonist, shows promising in vitro activity
Read More
Rheacell begins phase I/IIa study of allogeneic ABCB5-positive limbal stem cells for LSCD
Read More
Arena opens enrollment in phase III study of etrasimod for ulcerative colitis
Read More
Innate enrolling in phase II study of IPH-4102 in advanced T-cell lymphomas
Read More
Spero studies tebipenem pivoxil hydrobromide in phase III for cUTI or acute pyelonephritis
Read More
First-in-human results from HEPAVAC-101 study presented
Read More
Ansun studies DAS-181 in phase III for lower tract PIV infections in immunocompromised patients
Read More
Newron delays start of phase II/III studies of evenamide for schizophrenia
Read More
Massachusetts Institute of Technology patents MYC inhibitors
Read More
FLX Bio presents new USP7 inhibitors
Read More
Bayer discloses PE inhibitors
Read More
New PRMT5 inhibitors patented by Merck and collaborators
Read More
Paradigm reports new real-world data on iPPS in knee osteoarthritis
Read More
Medshine Discovery divulges IAP inhibitors
Read More
FDA approves sNDA for Vraylar for bipolar depression
Read More
Phase III cohort of valoctocogene roxaparvovec meets criteria for regulatory review
Read More
Calidi collaborates with NIH to study therapeutic potential of oncolytic viruses delivered by MSCs
Read More